Novo Nordisk A/S logo

NVONovo Nordisk A/S

NVO Stock Price, Valuation & Chart | Novo Nordisk A/S

Compare

NVO Historical price chart

NVO Key Stats

Market Capitalization173.14B
PE Ratio9.66
EPS4.02
Trading Volume9.46M
Today's High/Low39.4/38.67
Dividend Yield4.51
52 Week High/Low64.16/35.12
Shares Outstanding4.46B
NVO Financial Statement
NVO Analyst ratings
NVO Analysis & performance metrics

NVO Company profile

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle…

NVO Management team

Management
Karsten Munk KnudsenCFO
Executive Vice President, Chief Financial Officer & Member of the Management Board
Maziar Mike DoustdarCEO
President, Chief Executive Officer & Member of the Management Board
Henrik Ehlers Wulff
Executive Vice President of CMC & Product Supply and Member of the Management Board
David S. Moore
Executive Vice President of US Operations & Member of Management Board
Thilde Hummel Bogebjerg
Executive Vice President of Quality, IT & Environmental Affairs and Member of Management Board
Emil Kongshøj Larsen
EVice President of International Operations & Member of Management Board
Ludovic Helfgott
Executive Vice President of Product & Portfolio Strategy and Member of Management Board
Martin Holst Lange
EVice President of R&D, Chief Scientific Officer and Member of the Management Board
Total 8 executives

NVO Frequently asked questions

What is Novo Nordisk A/S (NVO) Stock Price?

Current stock price of Novo Nordisk A/S (NVO) stock is $38.830. The stock price is -0.99% lower in the session. The intraday range can be seen from this page. Volume of Novo Nordisk A/S (NVO) stock is 9.46M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Novo Nordisk A/S (NVO) stock price going up or down today?

The stock price of Novo Nordisk A/S (NVO) can change with earnings, company news, and overall market sentiment. Novo Nordisk A/S operates in the Healthcare / Drug Manufacturers - General market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Novo Nordisk A/S stock expensive at its current price?

Whether Novo Nordisk A/S looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NVO on this page is 9.66. EPS on this page is 4.02. Compare those figures with peers and growth expectations before deciding if the current Novo Nordisk A/S price is justified.

How has the stock price of Novo Nordisk A/S (NVO) performed historically?

Historical performance for Novo Nordisk A/S (NVO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NVO reacted to past earnings and market events.

Should I buy Novo Nordisk A/S (NVO) stock, at this price?

Buying Novo Nordisk A/S (NVO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.